Nakamura Natsuko, Fujinami Kaoru, Mizuno Yoshinobu, Noda Toru, Tsunoda Kazushige
Laboratory of Visual Physiology, Division of Vision Research, National Institute of Sensory Organs.
Department of Ophthalmology, National Hospital Organization, National Tokyo Medical Center, Tokyo, Japan.
Clin Ophthalmol. 2016 Jun 30;10:1175-85. doi: 10.2147/OPTH.S104721. eCollection 2016.
Full-field electroretinograms (ERGs) are used to evaluate retinal function in patients with various types of hereditary and acquired retinal diseases. However, ERG recordings require relatively invasive procedures, including pupillary dilation and the use of contact lens electrodes. Thus, it would be helpful to have a simpler and noninvasive screening method. The purpose of this study was to determine whether a new, handheld, portable ERG device, RETeval™, can be used to screen patients for cone dysfunction.
Thirty-five eyes of 35 patients who had reduced cone responses ascertained by a conventional ERG system using contact lens electrodes were studied. The causative diseases included achromatopsia, cone dystrophy, cone-rod dystrophy, retinitis pigmentosa, choroidal dystrophy, autoimmune retinopathy, and Stargardt disease. The flicker ERGs were recorded with the RETeval™ under undilated conditions with skin electrodes (stimulus strength, 3.0 cd·s/m(2); frequency, 28.3 Hz), and the responses were compared to that of 50 healthy eyes. The amplitudes and implicit times of the fundamental component of the flicker ERGs were analyzed in three age groups: Group A, ≤20 years; Group B, 21-40 years; and Group C, ≥41 years.
In all of the age groups, the amplitudes of the ERGs were significantly smaller and the implicit times significantly longer in patients with cone dysfunction than in the control eyes. All but one of the patients had flicker amplitudes lower than the mean -2.0 standard deviation of control eyes.
The RETeval™ has a potential of being used to screen for cone dysfunction. The entire examination takes <5 minutes and does not require pupil dilatation or a contact lens electrode. Although the flicker responses do not provide information on the scotopic functions, the RETeval™ device can be used to determine which patients require additional full-field ERG testing with dilated pupils under both scotopic and photopic conditions.
全视野视网膜电图(ERG)用于评估各类遗传性和获得性视网膜疾病患者的视网膜功能。然而,ERG记录需要相对侵入性的操作,包括瞳孔散大和使用接触镜电极。因此,拥有一种更简单且无创的筛查方法将很有帮助。本研究的目的是确定一种新型手持式便携式ERG设备RETeval™是否可用于筛查患者的视锥细胞功能障碍。
对35例患者的35只眼睛进行研究,这些患者通过使用接触镜电极的传统ERG系统确定视锥细胞反应降低。致病疾病包括色盲、视锥营养不良、视锥-视杆营养不良、色素性视网膜炎、脉络膜营养不良、自身免疫性视网膜病和斯塔加特病。使用RETeval™在未散瞳条件下用皮肤电极记录闪烁ERG(刺激强度,3.0 cd·s/m(2);频率,28.3 Hz),并将反应与50只健康眼睛的反应进行比较。在三个年龄组中分析闪烁ERG基本成分的振幅和隐含时间:A组,≤20岁;B组,21 - 40岁;C组,≥41岁。
在所有年龄组中,视锥细胞功能障碍患者的ERG振幅明显较小,隐含时间明显更长,与对照眼相比。除一名患者外,所有患者的闪烁振幅均低于对照眼平均值减2.0标准差。
RETeval™有用于筛查视锥细胞功能障碍的潜力。整个检查耗时<5分钟,不需要瞳孔散大或接触镜电极。尽管闪烁反应不提供暗视功能信息,但RETeval™设备可用于确定哪些患者需要在暗视和明视条件下散瞳进行额外的全视野ERG测试。